The disclosure pertains to medical devices and more particularly to delivery systems for replacement heart valves, and methods for using such medical devices and systems.
A wide variety of medical devices have been developed for medical use including, for example, medical devices utilized to replace heart valves. Heart function can be significantly impaired when a heart valve is not functioning properly. When the heart valve is unable to close properly, the blood within a heart chamber can regurgitate, or leak backwards through the valve. Valve regurgitation may be treated by replacing or repairing a diseased valve, such as an aortic valve. Surgical valve replacement is one method for treating the diseased valve, however this requires invasive surgical openings into the chest cavity and arresting of the patient's heart and cardiopulmonary bypass. Minimally invasive methods of treatment, such as transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR), generally involve the use of delivery catheters that are delivered through arterial passageways or other anatomical routes into the heart to replace the diseased valve with an implantable prosthetic heart valve.
In some cases, readjustment, recapture, or bail out with the replacement heart valve during implantation is desired. Of the known delivery systems and methods for implanting a prosthetic heart valve, each has certain advantages and disadvantages. There is an ongoing need to provide alternative delivery systems as well as alternative methods for manufacturing and using the medical devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. An example delivery system configured to deliver, adjust, and/or recapture a stent-valve includes an inner shaft having a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end, an expandable stent-valve configured to move between a compressed configuration and an expanded configuration, the stent-valve coupled to the inner shaft in the compressed configuration, the stent-valve having an upper portion including a plurality of arches and a plurality of radially outwardly extending upper anchoring crowns, a lower portion, and a valve, a distal sheath disposed over at least the lower portion of the stent-valve, a proximal sheath disposed over at least the upper portion of the stent-valve, and at least one cinching member coupled to the stent-valve and extending through one of the inner shaft, the distal sheath, or the proximal sheath, wherein the upper portion of the stent-valve is configured to move to the expanded configuration when the proximal sheath is withdrawn and the lower portion is configured to move to the expanded configuration when the distal sheath is withdrawn, wherein after at least a portion of the stent-valve has been moved to the expanded configuration, the at least one cinching member is configured to at least partially radially compress at least a portion of the stent-valve.
Alternatively or additionally to the embodiment above, the at least one cinching member is at least one suture coupled to the stent-valve.
Alternatively or additionally to any of the embodiments above, the suture has a middle region coupled to the stent-valve, and first and second free ends extending through at least one opening in the inner shaft and extending proximally through the inner shaft lumen and out a proximal end of the inner shaft, wherein pulling one or both free ends proximally causes the middle region to radially compress at least a portion of the heart-stent-valve.
Alternatively or additionally to any of the embodiments above, the middle region of the suture is positioned distal of the plurality of upper anchoring crowns.
Alternatively or additionally to any of the embodiments above, the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells, wherein the suture is coupled to at least two struts.
Alternatively or additionally to any of the embodiments above, the suture is a first suture positioned distal of the plurality of upper anchoring crowns, the delivery system further comprising a second suture coupled to the stent-valve, wherein the second suture is spaced apart from the first suture.
Alternatively or additionally to any of the embodiments above, wherein the at least one opening in the inner shaft includes a first opening positioned proximal of the distal end of the inner shaft, wherein at least one free end of the first suture extends through the first opening in the inner shaft, wherein at least one free end of the second suture extends through the distal end of the inner shaft, allowing the first and second sutures to be pulled independently or simultaneously to compress the lower portion of the stent-valve.
Alternatively or additionally to any of the embodiments above, the first and second sutures each extend around a circumference of the stent-valve.
Alternatively or additionally to any of the embodiments above, each of the first and second sutures extend around struts on opposite sides of the stent-valve.
Alternatively or additionally to any of the embodiments above, the suture includes first and second sutures each coupled to the stent-valve proximal of the upper crowns and extending proximally through the inner shaft lumen, the system further comprising third and fourth sutures coupled to at least two points of the distal end of the stent-valve and extending proximally through the inner shaft lumen.
Alternatively or additionally to any of the embodiments above, the delivery system further includes an outer shaft slidably disposed over the inner shaft, wherein the at last one suture includes first and second sutures each having a first end fixed to the inner shaft at a position proximal of the distal end of the inner shaft, and a second end coupled to the lower portion of the stent-valve, wherein when the outer shaft slides distally over the inner shaft, the outer shaft pulls the sutures radially inward causing the stent-valve to be compressed towards the inner shaft.
Alternatively or additionally to any of the embodiments above, the delivery system further includes a rod extending through the inner shaft, wherein the first and second free ends are twisted around the rod, such that rotating the rod pulls the middle region of the suture toward and into the inner shaft, thereby radially compressing the stent-valve.
Alternatively or additionally to any of the embodiments above, the inner shaft has an opening spaced proximally from the distal end of the inner shaft, wherein the first and second free ends of the suture are wrapped around an outer surface of the inner shaft proximally from the distal end and then extend into the opening, such that as the inner shaft is rotated, the suture wraps around the outer surface, shortening a middle region of the suture and pulling the stent-valve radially inward into the radially compressed configuration.
Alternatively or additionally to any of the embodiments above, the inner shaft has a distal tip, wherein the at least one suture includes a plurality of sutures each having a first end fixed to the distal tip, each suture coupled to the stent-valve and then extending into an opening in the inner shaft, the opening spaced proximally from the distal tip.
Alternatively or additionally to any of the embodiments above, the inner shaft has a distal tip, wherein the at least one cinching member includes a plurality of ribbons each having a first end fixed to the distal tip, the ribbon extending proximally and woven through the plurality of open cells and extending proximally along the inner shaft to the proximal end.
Alternatively or additionally to any of the embodiments above, the delivery system further includes an outer shaft slidably extending over the inner shaft, wherein the inner shaft has a distal tip, wherein the at least one cinching member includes a plurality of ribbons each having a first end fixed to the distal tip and a second end coupled to the outer shaft, the ribbon extending from the distal tip proximally and helically around an outer surface of the stent-valve, wherein the outer shaft is rotatable in an opposite direction as the inner shaft, thereby cinching the stent-valve as the ribbons contract radially inward.
Alternatively or additionally to any of the embodiments above, the inner shaft has a distal tip, wherein the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells, wherein at least some of the plurality of struts include distal extensions that converge into at least two paddles, wherein the at least one cinching member includes a capture member defined by the distal tip, the capture member configured to releasably engage the at least two paddles.
Alternatively or additionally to any of the embodiments above, the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells including lower open cells defining lower crowns, wherein the inner shaft has a distal tip, wherein the at least one cinching member includes a plurality of recapture members having first ends fixed to the distal tip and second ends defining hooks configured to releasably engage the lower open cells, wherein proximal movement of the distal sheath compresses the recapture members and the lower crowns radially inward, allowing the lower crowns to be re-inserted into the distal sheath.
Alternatively or additionally to any of the embodiments above, the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells including lower open cells defining a distal end of the stent-valve, wherein the at least one cinching member includes a plurality of hooks slidably extending from the distal end of the inner shaft, the hooks configured to engage the open cells and when pulled proximally, pull the distal end of the stent-valve into a radially contracted configuration.
Alternatively or additionally to any of the embodiments above, the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells including lower open cells defining lower crowns, wherein the at least one cinching member includes a plurality of release sheaths slidably extending out the distal end of the inner shaft, wherein a tether extends slidably through each of the plurality of release sheaths, out distal ends thereof and around at least one strut forming a bend in the tether, and a free distal end of the tether extends back into the release sheath, wherein each tether has a resting shape in which the bend is 90 degrees or less, wherein the tethers are configured such that when the release sheath is pulled proximally relative to the tether, once the free end of the tether is released from the release sheath, the tether returns to the resting shape thereby releasing the strut and allowing the tether to be withdrawn proximally from the stent-valve.
Alternatively or additionally to any of the embodiments above, the lower portion of the stent-valve includes a plurality of struts forming a plurality of open cells including lower open cells defining lower crowns, wherein the inner shaft has a distal tip, wherein the at least one cinching member includes an expandable mesh having a first end fixed to the distal tip and a second free end configured to extend over and surround the lower crowns, wherein the distal sheath is configured to be moved distally to allow the mesh and lower portion of the stent-valve to expand, and to be moved proximally to radially constrain the mesh and distal crowns.
Alternatively or additionally to any of the embodiments above, each of the plurality of upper anchoring crowns includes an extension connecting the upper crown to one of the plurality of arches, wherein the at least one cinching member includes a plurality of cinching members, each cinching member configured to extend distally from a delivery catheter and releasably engage one of the plurality of arches.
Alternatively or additionally to any of the embodiments above, the plurality of cinching members are sutures, wherein first and second free ends of each suture extend proximally through the delivery catheter and a middle portion of each suture forms a loop around one of the plurality of arches.
Alternatively or additionally to any of the embodiments above, the plurality of cinching members are hooks configured to extend distally from the distal end of the delivery catheter and releasably engage one of the plurality of arches.
Another delivery system configured to deliver, adjust, and/or recapture a stent-valve includes an inner shaft having a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end, an expandable stent-valve configured to move between a compressed configuration and an expanded configuration, the stent-valve coupled to the inner shaft in the compressed configuration, the stent-valve having an upper portion including a plurality of arches and a plurality of radially outwardly extending upper anchoring crowns, a lower portion, and a valve, the lower portion including a plurality of struts defining a plurality of open cells, a distal sheath disposed over at least the lower portion of the stent-valve a proximal sheath disposed over at least the upper portion of the stent-valve, and at least one cinching member coupled to the stent-valve and extending through one of the inner shaft, the distal sheath, or the proximal sheath, wherein the at least one cinching member is configured to gradually radially compress and release at least a portion of the stent-valve in the absence of the proximal and distal sheaths.
An example method of delivering and repositioning a stent-valve includes the step of inserting a distal tip of a stent-valve delivery system through a patient's aorta and aortic valve, the delivery system including an inner shaft including the distal tip, a stent-valve crimped onto the inner shaft, the stent-valve including an upper portion, a lower portion, and a valve, a distal sheath disposed over at least the lower portion of the stent-valve, a proximal sheath disposed over at least the upper portion of the stent-valve, and at least one cinching member coupled to at least the lower portion of the stent-valve and extending through one of the inner shafts, the distal sheath, or the proximal sheath. The method further includes the steps of moving the proximal sheath proximally to release the upper portion of the stent-valve, moving the distal sheath distally to release the lower portion of the stent-valve, cinching the cinching member thereby radially compressing at least the lower portion of the stent-valve, repositioning at least the lower portion of the stent-valve, and releasing the cinching member thereby allowing the lower portion of the stent-valve to expand.
The above summary of some embodiments, aspects, and/or examples is not intended to describe each embodiment or every implementation of the present disclosure. The figures and the detailed description which follows more particularly exemplify these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying drawings, in which:
While aspects of the disclosure are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about”, in the context of numeric values, generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (e.g., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.
The recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5). Although some suitable dimensions, ranges, and/or values pertaining to various components, features and/or specifications are disclosed, one of skill in the art, incited by the present disclosure, would understand desired dimensions, ranges, and/or values may deviate from those expressly disclosed.
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise. It is to be noted that in order to facilitate understanding, certain features of the disclosure may be described in the singular, even though those features may be plural or recurring within the disclosed embodiment(s). Each instance of the features may include and/or be encompassed by the singular disclosure(s), unless expressly stated to the contrary. For simplicity and clarity purposes, not all elements of the disclosure are necessarily shown in each figure or discussed in detail below. However, it will be understood that the following discussion may apply equally to any and/or all of the components for which there are more than one, unless explicitly stated to the contrary. Additionally, not all instances of some elements or features may be shown in each figure for clarity.
Relative terms such as “proximal”, “distal”, “advance”, “withdraw”, variants thereof, and the like, may be generally considered with respect to the positioning, direction, and/or operation of various elements relative to a user/operator/manipulator of the device, wherein “proximal” and “withdraw” indicate or refer to closer to or toward the user and “distal” and “advance” indicate or refer to farther from or away from the user. In some instances, the terms “proximal” and “distal” may be arbitrarily assigned in an effort to facilitate understanding of the disclosure, and such instances will be readily apparent to the skilled artisan. Other relative terms, such as “upstream”, “downstream”, “inflow”, and “outflow” refer to a direction of fluid flow within a lumen, such as a body lumen, a blood vessel, or within a device.
The term “extent” may be understood to mean a greatest measurement of a stated or identified dimension, unless the extent or dimension in question is preceded by or identified as a “minimum”, which may be understood to mean a smallest measurement of the stated or identified dimension. For example, “outer extent” may be understood to mean a maximum outer dimension, “radial extent” may be understood to mean a maximum radial dimension, “longitudinal extent” may be understood to mean a maximum longitudinal dimension, etc. Each instance of an “extent” may be different (e.g., axial, longitudinal, lateral, radial, circumferential, etc.) and will be apparent to the skilled person from the context of the individual usage. Generally, an “extent” may be considered a greatest possible dimension measured according to the intended usage, while a “minimum extent” may be considered a smallest possible dimension measured according to the intended usage. In some instances, an “extent” may generally be measured orthogonally within a plane and/or cross-section, but may be, as will be apparent from the particular context, measured differently-such as, but not limited to, angularly, radially, circumferentially (e.g., along an arc), etc.
The terms “monolithic” and “unitary” shall generally refer to an element or elements made from or consisting of a single structure or base unit/element. A monolithic and/or unitary element shall exclude structure and/or features made by assembling or otherwise joining multiple discrete elements together.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment(s) described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to affect the particular feature, structure, or characteristic in connection with other embodiments, whether or not explicitly described, unless clearly stated to the contrary. That is, the various individual elements described below, even if not explicitly shown in a particular combination, are nevertheless contemplated as being combinable or arrangeable with each other to form other additional embodiments or to complement and/or enrich the described embodiment(s), as would be understood by one of ordinary skill in the art.
For the purpose of clarity, certain identifying numerical nomenclature (e.g., first, second, third, fourth, etc.) may be used throughout the description and/or claims to name and/or differentiate between various described and/or claimed features. It is to be understood that the numerical nomenclature is not intended to be limiting and is exemplary only. In some embodiments, alterations of and deviations from previously-used numerical nomenclature may be made in the interest of brevity and clarity. That is, a feature identified as a “first” element may later be referred to as a “second” element, a “third” element, etc. or may be omitted entirely, and/or a different feature may be referred to as the “first” element. The meaning and/or designation in each instance will be apparent to the skilled practitioner.
The following description should be read with reference to the drawings, which are not necessarily to scale, wherein similar elements in different drawings are numbered the same. The detailed description and drawings are intended to illustrate but not limit the disclosure. Those skilled in the art will recognize that the various elements described and/or shown may be arranged in various combinations and configurations without departing from the scope of the disclosure. The detailed description and drawings illustrate example embodiments of the disclosure. However, in the interest of clarity and ease of understanding, while every feature and/or element may not be shown in each drawing, the feature(s) and/or element(s) may be understood to be present regardless, unless otherwise specified.
When implanting a TAVR type valve, proper positioning is critical for the proper functioning of the valve. Self-expanding TAVR valves often contain nitinol frames that are elastically compressed onto the delivery system and are released to expand into the aortic valve during the procedure. The proper position of the valve must be determined while valve is mostly compressed on delivery system. In most TAVR systems, the valve release from the delivery system occurs in less than a second. After release, readjustment, repositioning, recapture, or removal of the valve is often impossible without surgery. Improper positioning during delivery may result in ventricular or aortic migration which could cause serious complications for the patient. In many cases, the delivery system for implanting a TAVR type valve lacks features that allow physicians to adjust, reposition, recapture, or bail out with the implant after it is released from the delivery system.
Adding features to the delivery system and/or the implant that would give physicians full control of implant diameter during deployment increases the likelihood of properly positioning the valve during delivery. A controlled deployment may also allow for reversible expansion, and thus allow for repositioning if initial placement is not ideal. This may occur after only the upper portion 20 has been released or after complete deployment of the stent-valve 10, including both the upper portion 20 and the lower portion 22.
Further, providing features to the delivery system that allow the valve to be pulled out proximally without causing damage to the patient's anatomy is advantageous when it is desired to reverse the entire delivery process, particularly when the removal and bail out of the procedure can occur rapidly. The delivery systems described below provide various structures that allow for controlled expansion, adjustment, repositioning, and removal of the stent-valve after at least partial deployment of the stent-valve.
The conventional delivery system and method results in rapid expansion and seating of the stent-valve 10, without opportunity for modification of the position of the stent-valve. For example, the proximal sheath 40 may be withdrawn from the upper anchoring crowns 13 and the arches 11 in one movement, resulting in the arches 11 and upper anchoring crowns 13 being expanded radially outward beyond the inner diameter of the proximal sheath 40, as shown in
A number of different delivery systems and structures are described below, which allow for a controlled delivery of the stent-valve 10, allowing for radially compressing at least a portion of the stent-valve after the stent-valve has been fully expanded. This will allow for the stent-valve to be repositioned after deployment. Additionally, the delivery systems may provide for a slower and more controlled expansion of the stent-valve 10 compared to the near instantaneous prior art delivery systems and methods. In the delivery systems described below and shown in
In the embodiment shown in
Alternatively, the free ends of the suture may be manually pulled to compress the stent-valve, and then the free ends may be secured or locked against further axial movement, such as with a spring clip at the proximal end of the delivery catheter. To control the expansion of the lower portion 22 of the stent-valve during deployment, the free ends 31, 32 of the suture 30 may be pulled and held under tension as the distal sheath is removed from the stent-valve. This prevents the lower portion of the stent-valve from expanding rapidly as soon as the distal sheath 60 moves off the lower crowns 15. The suture 30 may be gradually released to allow for a gradual expansion of the lower portion 22 of the stent-valve, with readjustment of its position, if necessary. After adjusting or repositioning the stent-valve, when the stent-valve is fully expanded, one end of the suture may be released to pull the entire suture proximally out of the delivery system or if the ends of the suture are locked in place, the suture may be cut to allow for removal.
The degree of compression of the stent-valve 10 may be adjusted by pulling more or less of the suture free ends 31, 32 proximally out of the inner shaft 142. This may allow a fully expanded stent-valve 10 to be repositioned or readjusted. Once the stent-valve has been sufficiently radially compressed to release it from the native valve, the stent-valve may be repositioned. Once the stent-valve is in the desired position, the first free end 31 of the suture 30 may be released and the second 32 free end may be pulled proximally such that the free end 31 is pulled distally through the inner shaft 142 and then around the stent-valve 10 and back proximally through the inner shaft 142 to be completely removed from the inner shaft 142. In some embodiments, the first and second free ends 31, 32 of the suture 30 may be pulled tight enough such that the lower portion 22 of the stent-valve 10 is compressed until the distal sheath 60 can move proximally over at least the lower crowns 15. The stent-valve may then be moved into a more desirable position, at which time, the distal sheath may be moved distally and the suture removed as described above.
In the embodiment shown in
The lower portion of the stent-valve 10 may include a plurality of struts 17 forming a plurality of open cells 18, and the suture 30 may be coupled to at least two struts. As illustrated in
In another embodiment, the first end of the suture may be fixed to the stent-valve 10, and the remainder of the suture may extend around at least a portion of the circumference of the stent-valve with the free second end extending through the lumen of the inner shaft 142 and out the proximal end 145. The free end of the suture may be pulled proximally to cinch the stent-valve, and once the stent-valve has been repositioned or readjusted, the first end of the suture may be cut with a cutting implement extending through the inner shaft 142 or through the delivery catheter.
The free ends 31, 32 of all of the sutures 30 may enter the lumen of the inner shaft 142 through the distal end 144. Alternatively, some of the sutures 30 may extend into the distal end 144 while other sutures may enter one or more opening 148 through the side wall of the inner shaft 142 proximal of the distal end 144, as shown in
In a further embodiment, the first and second sutures 30a, 30b may be coupled to a portion of the stent-valve proximal of the upper anchoring crowns 13, and the third and fourth sutures 30c, 30d, may be coupled to struts 17 at the distal end of the stent-valve 10 as shown in
In the embodiments shown in
In each of the embodiments shown in
In a further embodiment, the cinching member may include a plurality of ribbons 70 configured to apply a radially inward compressing force on the stent-valve, as shown in
The embodiment shown in
In addition to the cinch members for controlling delivery of the stent-valve discussed above, the delivery system may include cinching or compressing members that allow the distal end of the stent-valve, including the lower crowns 15, to be recaptured into the distal sheath 60 for axial adjustment of the stent-valve 10. The controlled delivery structures described above may be used in combination with the recapturing structures described below.
In the embodiment shown in
In another embodiment, the cinching member may include a plurality of release sheaths 80 slidably disposed within the inner shaft 142, where each release sheath 80 has a tether 530 slidably disposed therein, as shown in
In some instances, a complete bail-out may desired, in which the fully expanded stent-valve 10 must be removed completely from the body. This bail-out procedure often needs to be performed rapidly to avoid injury to the patient. The upper anchoring crowns 13 in the stent-valve 10 shown in
The delivery system may further include a centering member 1230 configured to center the wires 1210 as they extend out of the claw device 1200 extending distal from the catheter 2. as shown in
In another embodiment, the centering member is a braided or woven mesh cone 1235 configured to expand into contact with the inner walls of the aorta 5, as shown in
In addition to the various cinching and compressing members described above, the stent-valve may include one or more cinching member engagement elements configured to hold the cinching or compressing members in place. For example, as shown in
The delivery system in accordance with any of the above described embodiments may be used in a method to deliver and reposition a replacement stent-valve. In some embodiments, the stent-valve may be used to replace the native aortic valve. In other embodiments, the stent-valve may be inserted into a failed replacement valve already implanted in the native aortic valve. The method of delivering and repositioning the stent-valve 10 may include inserting a distal tip of a stent-valve delivery system through a patient's aorta 5 and aortic valve 7, the delivery system including an inner shaft 142 including a distal tip 146, a stent-valve 10 crimped onto the inner shaft, the stent-valve including an upper portion 20, a lower portion 22, and a valve 14. The delivery system may further include a distal sheath 60 disposed over at least the lower portion of the stent-valve 10, a proximal sheath 40 disposed over at least the upper portion of the stent-valve 10, and at least one cinching member 30 coupled to at least the lower portion of the stent-valve 10 and extending through one of the inner shaft, the distal sheath, or the proximal sheath. The method further includes the steps of moving the proximal sheath 40 proximally to release the upper portion of the stent-valve, moving the distal sheath 60 distally to release the lower portion of the stent-valve, and cinching the cinching member 30 thereby radially compressing at least the lower portion of the stent-valve 10. The method may further include the steps of repositioning at least the lower portion of the stent-valve, and releasing the cinching member 30 thereby allowing the lower portion of the stent-valve to expand.
The materials that can be used for the various components of the delivery system (and/or other systems or components disclosed herein) and the various elements thereof disclosed herein may include those commonly associated with medical devices.
In some embodiments, delivery system (and variations, systems or components thereof disclosed herein) may be made from a metal, metal alloy, ceramics, zirconia, polymer (some examples of which are disclosed below), a metal-polymer composite, combinations thereof, and the like, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 444V, 444L, and 314LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; cobalt chromium alloys, titanium and its alloys, alumina, metals with diamond-like coatings (DLC) or titanium nitride coatings, other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R44035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R44003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; platinum; palladium; gold; combinations thereof; and the like; or any other suitable material.
As alluded to herein, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super-elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super-elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “super-elastic plateau” or “flag region” in its stress/strain curve like super-elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear than the super-elastic plateau and/or flag region that may be seen with super-elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.
In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super-elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super-elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also be distinguished based on its composition), which may accept only about 0.2 to 0.44 percent strain before plastically deforming.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by differential scanning calorimetry (DSC) and dynamic metal thermal analysis (DMTA) analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60 degrees Celsius (° C.) to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. For example, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a super-elastic alloy, for example a super-elastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of the delivery system (and variations, systems or components thereof disclosed herein) may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids a user in determining the location of the delivery system (and variations, systems or components thereof disclosed herein). Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands may also be incorporated into the design of the delivery system (and variations, systems or components thereof disclosed herein) to achieve the same result.
In some embodiments, portions of the delivery system (and variations, systems or components thereof disclosed herein), may be made from or include a polymer or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly (alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex® high-density polyethylene, Marlex® low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro (propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly (styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, polyurethane silicone copolymers (for example, Elast-Eon® from AorTech Biomaterials or ChronoSil® from AdvanSource Biomaterials), biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments, the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The disclosure's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of priority of U.S. Provisional Application No. 63/585,257 filed Sep. 26, 2023, the entire disclosure of which is hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
63585257 | Sep 2023 | US |